Fotherby K, Towobola O, Muggeridge J, Elder M G
Contraception. 1983 Nov;28(5):405-11. doi: 10.1016/0010-7824(83)90073-2.
There is concern that the breast-fed infant whose mother is receiving intra-muscular progestogens for contraception will be exposed to significant quantities of the steroid. Norethisterone levels in maternal serum and milk were studied throughout an injection interval after intramuscular administration of 200mg norethisterone oenanthate. Milk samples were taken at the beginning and at the end of the feed. Norethisterone concentrations in milk were very much lower, but declined more slowly, than serum concentrations. Post-suckling concentrations were higher than pre-suckling concentrations. Experiments in adults receiving an oral dose of norethisterone in cow's milk comparable to that ingested by an infant in a day resulted in low serum levels. It is concluded that only very low concentrations of norethisterone would be present in the infant's circulation.
有人担心,母亲接受肌内注射孕激素避孕的母乳喂养婴儿会接触到大量此类类固醇。在肌内注射200mg庚酸炔诺酮后的一个注射间隔内,对母体血清和乳汁中的炔诺酮水平进行了研究。在喂奶开始时和结束时采集乳汁样本。乳汁中的炔诺酮浓度比血清浓度低得多,但下降得更慢。喂奶后浓度高于喂奶前浓度。让成年人饮用与婴儿一天摄入量相当的掺有炔诺酮的牛奶,结果血清水平较低。得出的结论是,婴儿循环系统中只会存在极低浓度的炔诺酮。